Track topics on Twitter Track topics that are important to you
Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included
The post Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline appeared first on Pharma Business review.
Original Article: Harbour BioMed raises $85m to accelerate growth of therapeutic pipelineNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...